Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients
NCT03352674
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
133
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Insulin Glargine Ezelin
DRUG:
Insulin Glargine Pen Injector [Lantus]
Sponsor
Indonesia University